Product Description: Bersiporocin is a prolyl-tRNA synthetase inhibitor. Bersiporocin has an IC50 of ≤100 nM for phosphoribosylpyrophosphate synthetase (PRS). Bersiporocin can be used for the research of antifibrotic[1][2].
Applications: COVID-19-anti-virus
Formula: C15H19Cl2N3O
References: [1]Bong-Yong Lee, et al. Heterocyclic compounds, preparation methods, pharmaceutical compositions, and use as pyrolyl-tRNA synthetase inhibitors.WO2018147626 A1/[2]WHO Drug Information, Vol. 35, No. 4, 2021. Geneva: World Health Organization; 2022.
CAS Number: 2241808-52-4
Molecular Weight: 328.24
Compound Purity: 98.99
Research Area: Inflammation/Immunology
Solubility: DMSO : ≥ 100 mg/mL
Target: DNA/RNA Synthesis